196 related articles for article (PubMed ID: 9858029)
1. Functional polymorphism of -141C Ins/Del in the dopamine D2 receptor gene promoter and schizophrenia.
Ohara K; Nagai M; Tani K; Nakamura Y; Ino A; Ohara K
Psychiatry Res; 1998 Nov; 81(2):117-23. PubMed ID: 9858029
[TBL] [Abstract][Full Text] [Related]
2. [No association of 141C-ins/del polymorphism in the D2 dopamine receptor gene in schizophrenia].
Rohrmeier T; Putzhammer A; Sartor H; Knapp M; Albus M; Borrmann-Hassenbach M; Lichtermann D; Wildenauer D; Schwab S; Maier W; Klein HE; Eichhammer P
Psychiatr Prax; 2003 May; 30 Suppl 2():S212-5. PubMed ID: 14509080
[TBL] [Abstract][Full Text] [Related]
3. Dopamine receptor D2 -141C Insertion/Deletion polymorphism in a Finnish population with schizophrenia.
Kampman O; Anttila S; Illi A; Lehtimäki T; Mattila KM; Roivas M; Leinonen E
Psychiatry Res; 2003 Nov; 121(1):89-92. PubMed ID: 14572625
[TBL] [Abstract][Full Text] [Related]
4. Functional -141C Ins/Del polymorphism in the dopamine D2 receptor gene promoter and schizophrenia in a Chinese Han population.
Xiao L; Shen T; Peng DH; Shu C; Jiang KD; Wang GH
J Int Med Res; 2013 Aug; 41(4):1171-8. PubMed ID: 23816932
[TBL] [Abstract][Full Text] [Related]
5. The influence on the schizophrenic symptoms by the DRD2Ser/Cys311 and -141C Ins/Del polymorphisms.
Himei A; Koh J; Sakai J; Inada Y; Akabame K; Yoneda H
Psychiatry Clin Neurosci; 2002 Feb; 56(1):97-102. PubMed ID: 11929577
[TBL] [Abstract][Full Text] [Related]
6. The -141C Ins/Del polymorphism in the dopamine D2 receptor gene promoter region is associated with anxiolytic and antidepressive effects during treatment with dopamine antagonists in schizophrenic patients.
Suzuki A; Kondo T; Mihara K; Yasui-Furukori N; Ishida M; Furukori H; Kaneko S; Inoue Y; Otani K
Pharmacogenetics; 2001 Aug; 11(6):545-50. PubMed ID: 11505224
[TBL] [Abstract][Full Text] [Related]
7. A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia.
Arinami T; Gao M; Hamaguchi H; Toru M
Hum Mol Genet; 1997 Apr; 6(4):577-82. PubMed ID: 9097961
[TBL] [Abstract][Full Text] [Related]
8. The dopamine D2 receptor 5'-flanking variant, -141C Ins/Del, is not associated with reduced dopamine D2 receptor density in vivo.
Pohjalainen T; Någren K; Syvälahti EK; Hietala J
Pharmacogenetics; 1999 Aug; 9(4):505-9. PubMed ID: 10780270
[TBL] [Abstract][Full Text] [Related]
9. Analysis of methylation and -141C Ins/Del polymorphisms of the dopamine receptor D2 gene in patients with schizophrenia.
Funahashi Y; Yoshino Y; Yamazaki K; Ozaki Y; Mori Y; Mori T; Ochi S; Iga JI; Ueno SI
Psychiatry Res; 2019 Aug; 278():135-140. PubMed ID: 31176829
[TBL] [Abstract][Full Text] [Related]
10. The -141C Ins/Del and Taq1A polymorphism in the dopamine D2 receptor gene may confer susceptibility to schizophrenia in Asian populations.
Wang Y; Liu L; Xin L; Fan D; Ding N; Hu Y; Cai G; Wang L; Xia Q; Li X; Yang X; Zou Y; Pan F
J Clin Neurosci; 2016 Aug; 30():1-7. PubMed ID: 27283386
[TBL] [Abstract][Full Text] [Related]
11. Association between a promoter polymorphism in the dopamine D2 receptor gene and schizophrenia.
Jönsson EG; Nöthen MM; Neidt H; Forslund K; Rylander G; Mattila-Evenden M; Asberg M; Propping P; Sedvall GC
Schizophr Res; 1999 Nov; 40(1):31-6. PubMed ID: 10541004
[TBL] [Abstract][Full Text] [Related]
12. -141C insertion/deletion polymorphism of the dopamine D2 receptor gene is associated with schizophrenia in Chinese Han population: Evidence from an ethnic group-specific meta-analysis.
Zhao X; Huang Y; Chen K; Li D; Han C; Kan Q
Asia Pac Psychiatry; 2016 Sep; 8(3):189-98. PubMed ID: 26346037
[TBL] [Abstract][Full Text] [Related]
13. No relationship between--141C Ins/Del polymorphism in the promoter region of dopamine D2 receptor and extrapyramidal adverse effects of selective dopamine D2 antagonists in schizophrenic patients: a preliminary study.
Mihara K; Kondo T; Suzuki A; Yasui N; Ono S; Otani K; Kaneko S
Psychiatry Res; 2001 Feb; 101(1):33-8. PubMed ID: 11223117
[TBL] [Abstract][Full Text] [Related]
14. [Lack of association between 141C Ins/Del promoter polymorphism of DRD2 gene and schizophrenia].
Kapelski P; Czerski PM; Godlewski S; Dmitrzak-Weglarz M; Hauser J
Psychiatr Pol; 2002; 36(3):413-9. PubMed ID: 12149917
[TBL] [Abstract][Full Text] [Related]
15. Insertion/deletion variant (-141C Ins/Del) in the 5' regulatory region of the dopamine D2 receptor gene: lack of association with schizophrenia and bipolar affective disorder. Short communication.
Stöber G; Jatzke S; Heils A; Jungkunz G; Knapp M; Mössner R; Riederer P; Lesch KP
J Neural Transm (Vienna); 1998; 105(1):101-9. PubMed ID: 9588764
[TBL] [Abstract][Full Text] [Related]
16. Association between the DRD2-141C Insertion/Deletion polymorphism and schizophrenia.
Cordeiro Q; Siqueira-Roberto J; Zung S; Vallada H
Arq Neuropsiquiatr; 2009 Jun; 67(2A):191-4. PubMed ID: 19547807
[TBL] [Abstract][Full Text] [Related]
17. [Association of schizophrenia with a promoter polymorphism in the dopamine D2 receptor gene].
Peng DH; Wang GH; Cheng ZL; Zhang DX; Jiang KD
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Feb; 22(1):94-5. PubMed ID: 15696493
[TBL] [Abstract][Full Text] [Related]
18. -141C Ins/Del polymorphism of the dopamine D2 receptor gene is associated with schizophrenia in a Spanish population.
Lafuente A; Bernardo M; Mas S; Crescenti A; Aparici M; Gassó P; Goti J; Sanchez V; Catalan R; Carne X
Psychiatr Genet; 2008 Jun; 18(3):122-7. PubMed ID: 18496209
[TBL] [Abstract][Full Text] [Related]
19. Association study between the -141C Ins/Del and TaqI A polymorphisms of the dopamine D2 receptor gene and alcoholism.
Ishiguro H; Arinami T; Saito T; Akazawa S; Enomoto M; Mitushio H; Fujishiro H; Tada K; Akimoto Y; Mifune H; Shioduka S; Hamaguchi H; Toru M; Shibuya H
Alcohol Clin Exp Res; 1998 Jun; 22(4):845-8. PubMed ID: 9660310
[TBL] [Abstract][Full Text] [Related]
20. Dopamine D2 receptor gene -141C Insertion/Deletion polymorphism in Turkish schizophrenic patients.
Kurt H; Dikmen M; Basaran A; Yenilmez C; Ozdemir F; Degirmenci I; Gunes HV; Kucuk MU; Mutlu F
Mol Biol Rep; 2011 Feb; 38(2):1407-11. PubMed ID: 20665240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
